Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02008591
Collaborator
(none)
120
1
3
26
4.6

Study Details

Study Description

Brief Summary

The primary objective of this study is to compare the onset and duration of the initial dose of medications given through three different epidural (conventional epidural, combined spinal epidural and dural puncture epidural) techniques for labor pain relief.

The secondary objective of this study is to compare the fetal effects of these three epidural labor analgesia techniques.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial with computer generated (Microsoft Excel 2015) assignment placed in sealed envelopes.Randomized controlled trial with computer generated (Microsoft Excel 2015) assignment placed in sealed envelopes.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Anesthesiologist performing technique and bedside nurse instructed not to reveal randomization arm to the patient or study co-investigator who was waiting outside the room, and notified only after completion of the neuraxial placement protocol.
Primary Purpose:
Treatment
Official Title:
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
Actual Study Start Date :
Nov 26, 2013
Actual Primary Completion Date :
Jan 27, 2016
Actual Study Completion Date :
Jan 27, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Epidural Technique

Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min

Procedure: Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique
Three different techniques, using the same medications (bupivacaine and fentanyl)

Active Comparator: Combined Spinal Epidural Technique

Bupivacaine 2.5 mg with Fentanyl 25 mcg

Procedure: Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique
Three different techniques, using the same medications (bupivacaine and fentanyl)

Active Comparator: Dural Puncture Epidural Technique

Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min

Procedure: Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique
Three different techniques, using the same medications (bupivacaine and fentanyl)

Outcome Measures

Primary Outcome Measures

  1. Maternal Outcomes [Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours]

    Onset, quality, and duration of analgesia, occurrences of hypotension, bradycardia, pruritus, nausea, emesis.

Secondary Outcome Measures

  1. Fetal Outcomes [Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours]

    Occurrence of fetal bradycardia or other heart rate changes, changes in fetal heart tracing patterns

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    1. Nulliparous (first baby) parturient 2. Singleton, vertex gestation at term (37-42 weeks) 3. Less than 5 cm dilation 4. Desires an epidural technique for labor analgesia
Exclusion Criteria:
    1. Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes) 2. Any contraindication to the administration of an epidural technique 3. History of hypersensitivity or idiosyncratic reaction to local anesthetic or opioid medications 4. Current or historical evidence of a disease which may result in the risk of a cesarean delivery.
  1. Evidence of anticipated fetal anomalies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brigham and Women's Hospital Boston Massachusetts United States 02115

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

  • Principal Investigator: Lawrence C Tsen, MD, Brigham and Women's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lawrence Ching Tsen, Associate Professor, Harvard Medical School, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT02008591
Other Study ID Numbers:
  • 2013P001927
First Posted:
Dec 11, 2013
Last Update Posted:
Jan 24, 2017
Last Verified:
Jan 1, 2017
Keywords provided by Lawrence Ching Tsen, Associate Professor, Harvard Medical School, Brigham and Women's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2017